<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26418222</article-id><article-id pub-id-type="pmc">4587912</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0133697</article-id><article-id pub-id-type="publisher-id">PONE-D-14-40744</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>High Intensity Exercise in Multiple Sclerosis: Effects on Muscle Contractile Characteristics and Exercise Capacity, a Randomised Controlled Trial</article-title><alt-title alt-title-type="running-head">High Intensity Exercise in Multiple Sclerosis</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Wens</surname><given-names>Inez</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Dalgas</surname><given-names>Ulrik</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Vandenabeele</surname><given-names>Frank</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="author-notes" rid="econtrib001">
<sup>&#x02021;</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Grevendonk</surname><given-names>Lotte</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="author-notes" rid="econtrib001">
<sup>&#x02021;</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Verboven</surname><given-names>Kenneth</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="author-notes" rid="econtrib001">
<sup>&#x02021;</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hansen</surname><given-names>Dominique</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="author-notes" rid="econtrib001">
<sup>&#x02021;</sup>
</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Eijnde</surname><given-names>Bert O.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff001">
<label>1</label>
<addr-line>REVAL Rehabilitation Research Center, BIOMED Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Agoralaan Building A, Diepenbeek, Belgium</addr-line>
</aff><aff id="aff002">
<label>2</label>
<addr-line>Section of Sport Science, Dep. Public Health, Aarhus University, Dalgas Avenue 4, 8000, Aarhus, C, Denmark</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Earnest</surname><given-names>Conrad P.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>Texas A&#x00026;M University, UNITED STATES</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>Inez Wens received support from MS Fund Limburg, Flanders, to perform this research. Ulrik Dalgas has received research support, travel grants and/or teaching honorary from Biogen Idec, Merck Serono and Sanofi Aventis and further serves as PI for the ongoing Biogen sponsored ACTIMS study. Frank Vandenabeele, Maartje Krekels, Lotte Grevendonk, Kenneth Verboven and Dominique Hansen report no disclosure. Bert Op &#x02019;t Eijnde received support from MS Fund Limburg, Flanders, to perform this research. This does not alter our adherence to Plos One policies on sharing data and materials.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: IW UD BOE. Performed the experiments: IW FV LG KV DH. Analyzed the data: IW UD BOE. Contributed reagents/materials/analysis tools: IW UD BOE. Wrote the paper: IW UD FV LG KV DH BOE.</p></fn><fn fn-type="other" id="econtrib001"><p>&#x02021; These authors also contributed equally to this work.</p></fn><corresp id="cor001">* E-mail: <email>inez.wens@uhasselt.be</email></corresp></author-notes><pub-date pub-type="epub"><day>29</day><month>9</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>10</volume><issue>9</issue><elocation-id>e0133697</elocation-id><history><date date-type="received"><day>13</day><month>11</month><year>2014</year></date><date date-type="accepted"><day>30</day><month>6</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2015 Wens et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Wens et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0133697.pdf"/><abstract><sec id="sec001"><title>Introduction</title><p>Low-to-moderate intensity exercise improves muscle contractile properties and endurance capacity in multiple sclerosis (MS). The impact of high intensity exercise remains unknown.</p></sec><sec id="sec002"><title>Methods</title><p>Thirty-four MS patients were randomized into a sedentary control group (SED, n = 11) and 2 exercise groups that performed 12 weeks of a high intensity interval (H<sub>IT</sub>R, n = 12) or high intensity continuous cardiovascular training (H<sub>CT</sub>R, n = 11), both in combination with resistance training. M.vastus lateralis fiber cross sectional area (CSA) and proportion, knee-flexor/extensor strength, body composition, maximal endurance capacity and self-reported physical activity levels were assessed before and after 12 weeks.</p></sec><sec id="sec003"><title>Results</title><p>Compared to SED, 12 weeks of high intensity exercise increased mean fiber CSA (H<sub>IT</sub>R: +21&#x000b1;7%, H<sub>CT</sub>R: +23&#x000b1;5%). Furthermore, fiber type I CSA increased in H<sub>CT</sub>R (+29&#x000b1;6%), whereas type II (+23&#x000b1;7%) and IIa (+23&#x000b1;6%,) CSA increased in H<sub>IT</sub>R. Muscle strength improved in H<sub>IT</sub>R and H<sub>CT</sub>R (between +13&#x000b1;7% and +45&#x000b1;20%) and body fat percentage tended to decrease (H<sub>IT</sub>R: -3.9&#x000b1;2.0% and H<sub>CT</sub>R: -2.5&#x000b1;1.2%). Furthermore, endurance capacity (W<sub>max</sub> +21&#x000b1;4%, time to exhaustion +24&#x000b1;5%, VO<sub>2max</sub> +17&#x000b1;5%) and lean tissue mass (+1.4&#x000b1;0.5%) only increased in H<sub>IT</sub>R. Finally self-reported physical activity levels increased 73&#x000b1;19% and 86&#x000b1;27% in H<sub>CT</sub>R and H<sub>IT</sub>R, respectively.</p></sec><sec id="sec004"><title>Conclusion</title><p>High intensity cardiovascular exercise combined with resistance training was safe, well tolerated and improved muscle contractile characteristics and endurance capacity in MS.</p></sec><sec id="sec005"><title>Trial Registration</title><p>ClinicalTrials.gov <ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov/ct2/show/NCT01845896">NCT01845896</ext-link>
</p></sec></abstract><funding-group><funding-statement>This work was supported by MS Fund, Limburg, Flanders, Belgium. Ulrik Dalgas has received research support, travel grants and/or teaching honorary from Biogen Idec, Merck Serono and Sanofi Aventis and further serves as PI for the ongoing Biogen sponsored ACTIMS study. This does not alter our adherence to Plos One policies on sharing data and materials. Furthermore, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="3"/><page-count count="13"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec006"><title>Introduction</title><p>The heterogeneous symptoms of multiple sclerosis (MS) often lead to a more sedentary lifestyle [<xref rid="pone.0133697.ref001" ref-type="bibr">1</xref>]. This may result in disuse-related loss of exercise capacity and muscle strength, which in turn can affect quality of life [<xref rid="pone.0133697.ref002" ref-type="bibr">2</xref>]. Increasing evidence favors exercise therapy as a method for overall symptom management [<xref rid="pone.0133697.ref003" ref-type="bibr">3</xref>]. Observational [<xref rid="pone.0133697.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0133697.ref005" ref-type="bibr">5</xref>] as well as interventional studies [<xref rid="pone.0133697.ref006" ref-type="bibr">6</xref>&#x02013;<xref rid="pone.0133697.ref009" ref-type="bibr">9</xref>] have reported improvements in exercise tolerance, muscle strength, functional capacity and health-related quality of life after low-to-moderate intensity cardiovascular or resistance training. Although combined cardiovascular and resistance training could, from a theoretical point of view, positively affect both the cardiovascular system and muscle strength/activation[<xref rid="pone.0133697.ref010" ref-type="bibr">10</xref>], this type of rehabilitation/exercise therapy has not been investigated extensively [<xref rid="pone.0133697.ref011" ref-type="bibr">11</xref>&#x02013;<xref rid="pone.0133697.ref015" ref-type="bibr">15</xref>].</p><p>Several authors already suggested that MS patients could benefit more from higher training intensities [<xref rid="pone.0133697.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0133697.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0133697.ref017" ref-type="bibr">17</xref>], but so far, no studies on combined exercise have evaluated high intensity training in MS. In healthy controls (HC) and in other populations, high intensity exercise and high intensity interval training (H<sub>IT</sub>) have previously been investigated, showing profound improvements in endurance performance and muscle strength [<xref rid="pone.0133697.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0133697.ref019" ref-type="bibr">19</xref>], reduced subcutaneous and abdominal fat [<xref rid="pone.0133697.ref020" ref-type="bibr">20</xref>], improved functional recovery (after stroke) [<xref rid="pone.0133697.ref021" ref-type="bibr">21</xref>] and beneficial effects to the heart [<xref rid="pone.0133697.ref022" ref-type="bibr">22</xref>], emphasising the need to investigate this in MS.</p><p>To date the impact of MS on skeletal muscle characteristics, such as muscle fiber cross sectional area (CSA) and proportion remains unclear. Recently, we reported reduced muscle fiber CSA and changed fiber proportions in MS patients, compared to HC [<xref rid="pone.0133697.ref023" ref-type="bibr">23</xref>]. The impact of exercise on muscle contractile properties in MS has only been investigated by Dalgas and co-workers [<xref rid="pone.0133697.ref024" ref-type="bibr">24</xref>]. They reported increased m.vastus lateralis mean fiber CSA combined with improved muscle strength following 12 weeks of progressive resistance training. Despite the importance of understanding the effects of exercise on muscle fiber characteristics to optimize exercise and rehabilitations programs in MS, the impact of other training modalities and intensities on muscle fiber CSA and fiber type proportion in MS, has not been investigated yet.</p><p>To determine the effects of high intensity exercise in MS, this study aimed to investigate the impact of high intensity interval or continuous cardiovascular exercise, both in combination with resistance training, on muscle contractile characteristics, in terms of muscle fiber CSA/proportion, muscle strength and muscle mass and on endurance capacity in MS. It was hypothesized that the applied intense programs could improve mean muscle fiber CSA and proportion as well as muscle strength and endurance capacity.</p></sec><sec sec-type="materials|methods" id="sec007"><title>Methods</title><sec id="sec008"><title>Participants</title><p>Thirty-four MS patients diagnosed according to McDonald criteria (EDSS range 1&#x02013;5), aged &#x0003e;18 years, were included following written informed consent (<xref rid="pone.0133697.g001" ref-type="fig">Fig 1</xref>). Subjects were excluded if they had other disorders (cancer, cardiovascular, pulmonary and/or renal), were pregnant, participated in another study, were already physical active, had an acute MS-exacerbation 6 months prior to the start of the study or contra-indications to perform physical exercise.</p><fig id="pone.0133697.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0133697.g001</object-id><label>Fig 1</label><caption><title>Consort flow diagram for participants&#x02019; inclusion.</title></caption><graphic xlink:href="pone.0133697.g001"/></fig><p>The study was approved by the ethical committee of Jessa Hospital Hasselt (<xref rid="pone.0133697.s002" ref-type="supplementary-material">S1 Protocol</xref>) and Hasselt University (12/02/2013), whereupon the preparation of the study started in March 2013 (to order the appropriate equipment, to organise info sessions etc.). Next, this study was registered at ClinicalTrials.gov (NCT01845896, initial release 30/04/2013), at the beginning of patient recruitment (April-June). Furthermore, the authors confirm that all on-going and related trials for this intervention are registered. Finally, all tests were performed in accordance with the Declaration of Helsinki.</p></sec><sec id="sec009"><title>Study design overview</title><p>All MS patients were randomized, by means of sealed envelopes, into a sedentary control group (SED, n = 11) and 2 exercise groups that performed 12 weeks of a high intensity interval + resistance training (H<sub>IT</sub>R, n = 12) or high intensity continuous endurance + resistance training (H<sub>CT</sub>R, n = 11). M.vastus lateralis fiber CSA and proportion, knee flexor and extensor strength, body composition, maximal endurance capacity and self-reported physical activity levels were assessed before and after the intervention. Neither the patients nor the researchers involved in the project were blinded to group allocation. SED remained physical inactive during the study course and were instructed to continue their current level of physical activity during the period of the study (<xref rid="pone.0133697.s001" ref-type="supplementary-material">S1 CONSORT Checklist</xref>).</p></sec><sec id="sec010"><title>Exercise intervention program</title><p>After the baseline measurements, the subjects were enrolled in a well-controlled and supervised training program, to increase cardiorespiratory fitness, as well as strength of the major peripheral muscle groups. Subjects participated in 5 sessions per 2 weeks. Training sessions were interspersed by at least one day of rest, to ensure adequate recovery. Each session started with endurance training, followed by resistance training, interspersed by a short resting period.</p><p>
<italic>H</italic>
<sub><italic>IT</italic></sub>
<italic>R program</italic>: Each session started with a 5min warm-up on a cycle ergometer. Hereafter, high intensity cycle interval training was performed. During the first 6 weeks exercise duration gradually increased from 5x1min interspersed by 1min rest intervals to 5x2min and 1min rest intervals. Exercise intensity was defined as the heart rate, corresponding to 100% of the maximal workload (which was comparable to approximately 80&#x02013;90% of the maximal heart rate). During the second 6 weeks, duration remained stable at 5x2min and the heart rate increased to reach a level corresponding to 100&#x02013;120% of the maximal work load (which was comparable to approximately 90&#x02013;100% of the initial maximal heart rate). The second part consisted of moderate-to-high intensity resistance training (leg press, leg curl, leg extension, vertical traction, arm curl and chest press, Technogym). In order to exercise at similar relative workload, resistance training of the lower limb was performed unilaterally, due to the frequent bilateral strength differences seen between the legs of MS patients.[<xref rid="pone.0133697.ref025" ref-type="bibr">25</xref>] Training intensity and volume were adjusted from 1x10 repetitions to 2x20 repetitions at maximal attainable load. Maximal attainable load was expressed as the maximal load that the subject was able to manage, under guidance and consequent encouragement. By applying the same standardised encouragements in all groups, subjects were stimulated to perform at their personal maximal ability.</p><p>
<italic>H</italic>
<sub><italic>CT</italic></sub>
<italic>R program</italic>: Each session started with a cardiovascular part, consisting of cycling and treadmill walking/running (Technogym). Session duration and exercise intensity increased as the intervention progressed, starting from 1x6min/session to 2x10min/session, at a high workload, corresponding to 80&#x02013;90% of maximal heart rate and according to individual capabilities. The second part of the training session comprised similar resistance training, as described in the H<sub>IT</sub>R program.</p><p>All exercises were performed at a high workload corresponding to 14&#x02013;16 ratings of perceived exertion on 20-point Borg scale (RPE) and were adjusted to individual disability level. The Borg Rating of Perceiver Exertion Scale measures perceived exertion and is used to document the person&#x02019;s exertion during a test or to assess the intensity of training and rehabilitation. The scale ranges from 6 to 20, where 6 means &#x0201c;no exertion at all&#x0201d; and 20 means &#x0201c;maximal exertion&#x0201d;. Continuous encouragement by the instructors led to a systematic increase of the training load over the 12-week training period. All sessions were ended by stretching of the extremities, and RPE-level was recorded.</p></sec><sec id="sec011"><title>Primary outcome measure</title><sec id="sec012"><title>1. Muscle fiber CSA and proportion</title><p>To investigate muscle fiber CSA and proportion, muscle biopsies form the middle part of the m.vastus lateralis (Bergstr&#x000f6;m needle technique) of the weakest leg (see isometric muscle strength measurements) were collected by an experienced medical doctor. The second biopsy, following 12 weeks of exercise or usual care, was taken 2-3cm proximal to the biopsy taken at baseline. Muscle samples were immediately mounted with Tissue-Tek, frozen in isopentane cooled with liquid nitrogen and stored at -80&#x000b0;C, until further analysis. The cross-sections of the biopsies, collected at baseline and after 12 weeks, were processed simultaneously.</p><p>Serial transverse sections (9&#x003bc;m) from the obtained muscle samples were cut at -20&#x000b0;C and stained by means of ATPase histochemistry, after preincubation at pH 4.4, 4.6 and 10.3, essentially following the procedure of Brooke and Kaiser [<xref rid="pone.0133697.ref026" ref-type="bibr">26</xref>]. The serial sections were visualized and analyzed using a Leica DM2000 microscope (Leica, Stockholm, Sweden) and a Leica Hi-resolution Color DFC camera (Leica, Stockholm, Sweden) combined with image-analysis software (Leica Qwin ver. 3, Leica, Stockholm, Sweden). A fiber mask of the stained sections was drawn automatically and afterwards this mask was fitted manually to the cell borders of the selected fibers. Only fibers cut perpendicularly to their longitudinal axis were used for the determination of fiber size. On average 170&#x000b1;10 fibers were calculated and included in the CSA and fiber type analyses.</p><p>Calculation of the fiber CSA was performed for the major fiber types (I, IIa and IIx) and for the mean fiber CSA, since the number of type IIax and IIc fibers was too small for statistical comparison and CSA calculation.</p></sec></sec><sec id="sec013"><title>Secondary outcome measures</title><p>Approximately 1&#x02013;2 weeks before the muscle biopsy was performed secondary outcome measures were assessed from all subjects.</p><sec id="sec014"><title>1. Isometric muscle strength</title><p>After 5min of warming-up on a cycle ergometer and following habitation, the maximal voluntary isometric muscle strength of the knee extensors and flexors (45&#x000b0; and 90&#x000b0; knee angle) were measured, as described elsewhere [<xref rid="pone.0133697.ref027" ref-type="bibr">27</xref>], using an isokinetic dynamometer (System 3, Biodex, ENRAF-NONIUS, New York, USA). Two maximal isometric extensions (4s) and flexions (4s), followed by a 30s rest interval, were performed. The highest isometric extension and flexion peak torques (Nm) were selected as the maximal isometric strength. Baseline results were used to classify the legs of each patient as weakest or strongest leg. This subdivision was maintained in further analysis, replacing a conventional left-right classification.</p></sec><sec id="sec015"><title>2. Endurance capacity</title><p>During the exercise test to volitional fatigue, an electronically braked cycle ergometer (eBike Basic, General Electric GmbH, Bitz, Germany) with pulmonary gas exchange analysis (Jaeger Oxycon, Erich Jaeger GmbH, Germany) was used (cycling frequency: 70 rpm). Jaeger calibration (ambient conditions, volume calibration and O<sub>2</sub>/CO<sub>2</sub> calibration) was performed at the start of each test day. This test was performed at least 48 hours separated from the isometric muscle strength test to exclude interference of muscle fatigue. Female and male MS patients started at 20W and 30W, respectively, during the first minute. Hereafter, workloads increased, respectively, 10W and 15W per minute. Oxygen uptake (VO<sub>2</sub>), expiratory volume (VE), and respiratory exchange ratio (RER) were collected breath-by-breath and averaged every 10 seconds. Using a 12-lead ECG device, heart rate (HR) was monitored every minute. At the end of the test RER values were evaluated to verify that the test was maximal (RER &#x02265; 1.15) [<xref rid="pone.0133697.ref028" ref-type="bibr">28</xref>]. In addition, maximal cycling resistance (W<sub>max</sub>), maximal heart rate (HR<sub>max</sub>), test duration and VO<sub>2max</sub>, defined as the corresponding load, heart rate, amount of minutes and oxygen uptake measured at the level of exhaustion, were reported.</p></sec><sec id="sec016"><title>3. Body composition</title><p>A Dual Energy X-ray Absorptiometry scan (Hologic Series Delphi-A Fan Beam X-ray Bone Densitometer, Vilvoorde, Belgium) was performed pre- en post-intervention. Fat and lean tissue mass were obtained for whole body, legs, trunk, gynoid and android region. Waist-to-hip fat mass ratio (android fat (g)/gynoid fat (g) ratio) and fat mass of the trunk/fat mass of the limbs ratio were calculated.</p></sec><sec id="sec017"><title>4. Physical activity level</title><p>Before and after the intervention, patients were asked to report their physical activity level by using the Physical Activity Scale for Individuals with Physical Disabilities (PASIPD) [<xref rid="pone.0133697.ref029" ref-type="bibr">29</xref>]. Respondents were asked to report the number of days and average hours in a day spent engaging in 13 activities (including recreational, household, and occupational activities) over the last 7 days. Frequency responses range from 1 (never) to 4 (often), and duration responses range from 1 (less than 1 hour) to 4 (more than 4 hours). Total scores were calculated as the product of the average hours spent in an activity daily and the metabolic equivalents (MET) summed over each item. Scores range from 0 (no activity) to over 100 MET*h/week (very high). At baseline all patients needed to be physical inactive, to be included in the study. Physical inactivity was defined as &#x0003c; 30 MET*h/week.</p></sec></sec><sec id="sec018"><title>Statistical analysis</title><p>All data were analyzed using SAS 9.2 software (SAS Institute Inc, Cary, USA). First normality was checked using the Shapiro-Wilk test for all variables. Differences between MS groups (SED, H<sub>CT</sub>R and H<sub>IT</sub>R) were analysed by a one-way ANOVA, whereas within group differences (post minus pre) were analysed with a paired student&#x02019;s t-test. Relative changes due to the intervention were calculated as the mean of the individual changes and expressed as a percentage. Correlations between changes of the primary and changes of the secondary outcome measures on grouped data from all groups were analysed by means of Pearson&#x02019;s correlation analysis. Multiple comparison was corrected by means of Bonferroni correction. All data are presented as mean&#x000b1;SE. P&#x0003c;0.01 represents the threshold for statistical significance.</p></sec></sec><sec sec-type="results" id="sec019"><title>Results</title><sec id="sec020"><title>Baseline subject characteristics and adherence to the intervention</title><p>At baseline, no differences in general subject and disease characteristics (<xref rid="pone.0133697.t001" ref-type="table">Table 1</xref>) as well as outcome measures were found between groups. Approximately 90% of the 30 supervised training sessions were attended in both exercise groups and no severe symptoms exacerbations and/or adverse events were reported. Furthermore, no patient drop out was noted.</p><table-wrap id="pone.0133697.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0133697.t001</object-id><label>Table 1</label><caption><title>Baseline subject and disease characteristics.</title><p>Data is presented as mean &#x000b1; SE. Differences between groups (SED, H<sub>CT</sub>R and H<sub>IT</sub>R) were analysed by a one-way ANOVA. Abbreviations used: MS, multiple sclerosis; SED, sedentary group; H<sub>CT</sub>R, intense continuous endurance + resistance training; H<sub>IT</sub>R, high intensity interval training + resistance training, BMI, body mass index; RR, relapsing remitting; CP, chronic progressive; EDSS, expanded disability status scale; immunomodulatory: interferon &#x003b2;, glatiramer acetate, fingolimod, natalizumab.</p></caption><alternatives><graphic id="pone.0133697.t001g" xlink:href="pone.0133697.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">SED (n = 11)</th><th align="center" rowspan="1" colspan="1">H<sub>CT</sub>R (n = 11)</th><th align="center" rowspan="1" colspan="1">H<sub>IT</sub>R (n = 12)</th><th align="center" rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>age (y)</bold>
</td><td align="center" rowspan="1" colspan="1">47&#x000b1;3</td><td align="center" rowspan="1" colspan="1">47&#x000b1;3</td><td align="center" rowspan="1" colspan="1">43&#x000b1;3</td><td align="center" rowspan="1" colspan="1">0.22</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>height (m)</bold>
</td><td align="center" rowspan="1" colspan="1">1.67&#x000b1;0.02</td><td align="center" rowspan="1" colspan="1">1.69&#x000b1;0.02</td><td align="center" rowspan="1" colspan="1">1.7&#x000b1;0.02</td><td align="center" rowspan="1" colspan="1">0.32</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>weight (kg)</bold>
</td><td align="center" rowspan="1" colspan="1">75.8&#x000b1;3.6</td><td align="center" rowspan="1" colspan="1">70.2&#x000b1;3.7</td><td align="center" rowspan="1" colspan="1">75.9&#x000b1;4.1</td><td align="center" rowspan="1" colspan="1">0.17</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>BMI (kg/m<sup>2</sup>)</bold>
</td><td align="center" rowspan="1" colspan="1">27.0&#x000b1;1.4</td><td align="center" rowspan="1" colspan="1">24.4&#x000b1;1.2</td><td align="center" rowspan="1" colspan="1">26.1&#x000b1;1.14</td><td align="center" rowspan="1" colspan="1">0.11</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Lean tissue mass (kg)</bold>
</td><td align="center" rowspan="1" colspan="1">43.2&#x000b1;2.1</td><td align="center" rowspan="1" colspan="1">45.4&#x000b1;2.6</td><td align="center" rowspan="1" colspan="1">48.5&#x000b1;3.1</td><td align="center" rowspan="1" colspan="1">0.11</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Fat percentage (%)</bold>
</td><td align="center" rowspan="1" colspan="1">38.2&#x000b1;2.1</td><td align="center" rowspan="1" colspan="1">33.6&#x000b1;2.8</td><td align="center" rowspan="1" colspan="1">36.2&#x000b1;1.9</td><td align="center" rowspan="1" colspan="1">0.20</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>gender (m/f)</bold>
</td><td align="center" rowspan="1" colspan="1">2/9</td><td align="center" rowspan="1" colspan="1">5/6</td><td align="center" rowspan="1" colspan="1">5/7</td><td align="center" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>type MS (RR/CP)</bold>
</td><td align="center" rowspan="1" colspan="1">8/3</td><td align="center" rowspan="1" colspan="1">8/3</td><td align="center" rowspan="1" colspan="1">10/2</td><td align="center" rowspan="1" colspan="1">0.8</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>EDSS</bold>
</td><td align="center" rowspan="1" colspan="1">2.5&#x000b1;0.3</td><td align="center" rowspan="1" colspan="1">2.7&#x000b1;0.3</td><td align="center" rowspan="1" colspan="1">2.3&#x000b1;0.3</td><td align="center" rowspan="1" colspan="1">0.41</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Immunomodulatory MS treatment</bold>
</td><td align="center" rowspan="1" colspan="1">72%</td><td align="center" rowspan="1" colspan="1">80%</td><td align="center" rowspan="1" colspan="1">80%</td><td align="center" rowspan="1" colspan="1">0.23</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec021"><title>Primary outcome measure</title><sec id="sec022"><title>1. Muscle fiber CSA and proportion</title><p>
<xref rid="pone.0133697.g002" ref-type="fig">Fig 2</xref> shows a representative image of muscle fiber types before and after high intensity exercise. In SED muscle fiber CSA and proportion did not change (p&#x0003e;0.05). Mean CSA significantly increased in H<sub>IT</sub>R and H<sub>CT</sub>R following 12 weeks of exercise (p = 0.009 and p = 0.002, respectively). Furthermore, muscle fiber type I CSA increased in H<sub>CT</sub>R (p = 0.003), whereas muscle fiber type II and IIa increased in H<sub>IT</sub>R (p = 0.007 and p = 0.002, respectively). Fiber type IIx CSA did not change (p&#x0003e;0.05). In general, no changes in fiber type proportion were observed in any exercise group after 12 weeks of exercise. However, within group effects were observed on type IIx of H<sub>CT</sub>R (p = 0.001), after comparison of the pre- and post-intervention fiber type proportion values (<xref rid="pone.0133697.t002" ref-type="table">Table 2</xref>).</p><fig id="pone.0133697.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0133697.g002</object-id><label>Fig 2</label><caption><title>Representative image of fiber type analysis before (left) and after (right) high intensity exercise.</title><p>Different fiber types are distinguished by color (dark blue: type I, pink: type IIa, green: type IIx, light blue: type IIc). Calculation of the fiber CSA was performed for the major fiber types (I, IIa and IIx) and for the mean fiber CSA, since the number of fibers expressing the minor fiber types (IIax and IIc) was too small for statistical comparison and CSA calculation.</p></caption><graphic xlink:href="pone.0133697.g002"/></fig><table-wrap id="pone.0133697.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0133697.t002</object-id><label>Table 2</label><caption><title>Muscle fiber type proportion and cross sectional area (CSA) at baseline and after 12 weeks of usual care or high intensity aerobic exercise in combination with resistance training.</title><p>Data are reported as mean &#x000b1; SE. Differences between groups (SED, H<sub>CT</sub>R and H<sub>IT</sub>R) were analysed by a one-way ANOVA, whereas within group differences (post minus pre) were analysed with a paired student&#x02019;s t-test. Relative changes due to the intervention were calculated as the mean of the individual changes and expressed as a percentage. Abbreviations used: SED, sedentary (usual care); H<sub>CT</sub>R, high intensity continuous exercise + resistance training; H<sub>IT</sub>R, high intensity interval training + resistance training.</p></caption><alternatives><graphic id="pone.0133697.t002g" xlink:href="pone.0133697.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th colspan="3" align="center" rowspan="1">SED</th><th colspan="3" align="center" rowspan="1">H<sub>CT</sub>R</th><th colspan="3" align="center" rowspan="1">H<sub>IT</sub>R</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Pre</th><th align="center" rowspan="1" colspan="1">Post</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">Pre</th><th align="center" rowspan="1" colspan="1">Post</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">Pre</th><th align="center" rowspan="1" colspan="1">Post</th><th align="center" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<underline><bold>Fiber type proportion (%)</bold></underline>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Type I</bold>
</td><td align="center" rowspan="1" colspan="1">44.2 &#x000b1; 3.9</td><td align="center" rowspan="1" colspan="1">47.5 &#x000b1; 2.9</td><td align="center" rowspan="1" colspan="1">
<bold>7.9 &#x000b1; 7.5</bold>
</td><td align="center" rowspan="1" colspan="1">40.1 &#x000b1; 4.7</td><td align="center" rowspan="1" colspan="1">46.9 &#x000b1; 4.7<xref rid="t002fn002" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>26.8 &#x000b1; 11.3</bold>
</td><td align="center" rowspan="1" colspan="1">41.3 &#x000b1; 3.0</td><td align="center" rowspan="1" colspan="1">46.3 &#x000b1; 2.6<xref rid="t002fn002" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>21.7 &#x000b1; 10.1</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Type IIa</bold>
</td><td align="center" rowspan="1" colspan="1">34.2 &#x000b1; 3.9</td><td align="center" rowspan="1" colspan="1">34.2 &#x000b1; 2.3</td><td align="center" rowspan="1" colspan="1">
<bold>5.1 &#x000b1; 13.1</bold>
</td><td align="center" rowspan="1" colspan="1">34.1 &#x000b1; 2.9</td><td align="center" rowspan="1" colspan="1">38.9 &#x000b1; 4.6</td><td align="center" rowspan="1" colspan="1">
<bold>6.6 &#x000b1; 7.5</bold>
</td><td align="center" rowspan="1" colspan="1">40.9 &#x000b1; 3.8</td><td align="center" rowspan="1" colspan="1">44.5 &#x000b1; 2.4</td><td align="center" rowspan="1" colspan="1">
<bold>6.9 &#x000b1; 8.1</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Type IIx</bold>
</td><td align="center" rowspan="1" colspan="1">21.2 &#x000b1; 4.5</td><td align="center" rowspan="1" colspan="1">17.7 &#x000b1; 2.0</td><td align="center" rowspan="1" colspan="1">
<bold>19.2 &#x000b1; 12.6</bold>
</td><td align="center" rowspan="1" colspan="1">24.3 &#x000b1; 2.7</td><td align="center" rowspan="1" colspan="1">13.5 &#x000b1; 2.6<xref rid="t002fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>-46.0 &#x000b1; 7.6</bold>
<xref rid="t002fn003" ref-type="table-fn">
<sup>c</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">18.5 &#x000b1; 2.8</td><td align="center" rowspan="1" colspan="1">10.1 &#x000b1; 2.8</td><td align="center" rowspan="1" colspan="1">
<bold>-20.1 &#x000b1; 25.4</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<underline><bold>Fiber CSA (&#x003bc;m<sup>2</sup>)</bold></underline>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Mean</bold>
</td><td align="center" rowspan="1" colspan="1">3738 &#x000b1; 267</td><td align="center" rowspan="1" colspan="1">3740 &#x000b1; 431</td><td align="center" rowspan="1" colspan="1">
<bold>3.5 &#x000b1; 4.3</bold>
</td><td align="center" rowspan="1" colspan="1">3551 &#x000b1; 351</td><td align="center" rowspan="1" colspan="1">3905 &#x000b1; 408<xref rid="t002fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>23.3 &#x000b1; 4.9</bold>
<xref rid="t002fn003" ref-type="table-fn">
<sup>c</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">4038 &#x000b1; 321</td><td align="center" rowspan="1" colspan="1">4892 &#x000b1;379<xref rid="t002fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>21.1 &#x000b1; 7.3</bold>
<xref rid="t002fn004" ref-type="table-fn">
<sup>d</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Type I</bold>
</td><td align="center" rowspan="1" colspan="1">4078 &#x000b1; 384</td><td align="center" rowspan="1" colspan="1">4050 &#x000b1; 531</td><td align="center" rowspan="1" colspan="1">
<bold>4.0 &#x000b1; 5.5</bold>
</td><td align="center" rowspan="1" colspan="1">3630 &#x000b1; 443</td><td align="center" rowspan="1" colspan="1">4071 &#x000b1; 470<xref rid="t002fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>29.8 &#x000b1; 5.5</bold>
<xref rid="t002fn003" ref-type="table-fn">
<sup>c</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">4410 &#x000b1; 188</td><td align="center" rowspan="1" colspan="1">4916 &#x000b1; 399</td><td align="center" rowspan="1" colspan="1">
<bold>12.1 &#x000b1; 8.7</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Type II</bold>
</td><td align="center" rowspan="1" colspan="1">3487 &#x000b1; 265</td><td align="center" rowspan="1" colspan="1">3478 &#x000b1; 334</td><td align="center" rowspan="1" colspan="1">
<bold>6.9 &#x000b1; 5.8</bold>
</td><td align="center" rowspan="1" colspan="1">3285 &#x000b1; 321</td><td align="center" rowspan="1" colspan="1">3622 &#x000b1; 398<xref rid="t002fn002" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>20.8 &#x000b1; 7.9</bold>
</td><td align="center" rowspan="1" colspan="1">3612 &#x000b1; 429</td><td align="center" rowspan="1" colspan="1">4551 &#x000b1; 462<xref rid="t002fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>22.7 &#x000b1; 6.8</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Type IIa</bold>
</td><td align="center" rowspan="1" colspan="1">3703 &#x000b1; 306</td><td align="center" rowspan="1" colspan="1">3729 &#x000b1; 402</td><td align="center" rowspan="1" colspan="1">
<bold>3.6 &#x000b1; 3.1</bold>
</td><td align="center" rowspan="1" colspan="1">3719 &#x000b1; 366</td><td align="center" rowspan="1" colspan="1">4014 &#x000b1; 522<xref rid="t002fn002" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>15.1 &#x000b1; 5.3</bold>
</td><td align="center" rowspan="1" colspan="1">4037 &#x000b1; 444</td><td align="center" rowspan="1" colspan="1">5034 &#x000b1; 447<xref rid="t002fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>22.8 &#x000b1; 6.2</bold>
<xref rid="t002fn004" ref-type="table-fn">
<sup>d</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Type IIx</bold>
</td><td align="center" rowspan="1" colspan="1">3446 &#x000b1; 305</td><td align="center" rowspan="1" colspan="1">3191 &#x000b1; 318</td><td align="center" rowspan="1" colspan="1">
<bold>5.4 &#x000b1; 8.2</bold>
</td><td align="center" rowspan="1" colspan="1">2771 &#x000b1; 277</td><td align="center" rowspan="1" colspan="1">2955 &#x000b1; 258</td><td align="center" rowspan="1" colspan="1">
<bold>14.5 &#x000b1; 8.9</bold>
</td><td align="center" rowspan="1" colspan="1">3187 &#x000b1; 438</td><td align="center" rowspan="1" colspan="1">3920 &#x000b1; 519<xref rid="t002fn002" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>23.6 &#x000b1; 8.8</bold>
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>
<sup>a</sup> p&#x0003c;0.01</p></fn><fn id="t002fn002"><p>
<sup>b</sup> p &#x02264; 0.05, compared with pre-intervention value, within group.</p></fn><fn id="t002fn003"><p>
<sup>c</sup> p&#x0003c;0.01</p></fn><fn id="t002fn004"><p>
<sup>d</sup> p &#x02264; 0.05, pre to post change compared with change from pre to post in SED.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="sec023"><title>Secondary outcome measures</title><sec id="sec024"><title>1. Isometric muscle strength</title><p>Muscle strength of SED remained stable during 12 weeks of usual care (p&#x0003e;0.05, <xref rid="pone.0133697.g003" ref-type="fig">Fig 3</xref>). Compared to SED, knee flexion and knee extension strength of the weakest leg of H<sub>IT</sub>R improved by 24&#x000b1;13 to 44&#x000b1;20% (p values between 0.01 and 0.006), whereas only hamstring strength of the strongest leg of H<sub>IT</sub>R improved by 13&#x000b1;7 to 20&#x000b1;7% (p = 0.006). Furthermore, H<sub>CT</sub>R flexion and extension strength improved, from pre- to post trial, in the weakest leg by 19&#x000b1;9 to 33&#x000b1;17% (p values between 0.01 and 0.006), whereas muscle strength of the strongest leg remained stable (p&#x0003e;0.05).</p><fig id="pone.0133697.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0133697.g003</object-id><label>Fig 3</label><caption><title>Percentage change of knee extension and flexion after 12 weeks of physical inactive living (usual care, SED), high intensity continuous training + resistance training (H<sub>CT</sub>R) and high intensity interval training + resistance training (H<sub>IT</sub>R).</title><p>Data are reported as mean &#x000b1; SE. * p&#x0003c;0.05, compared with pre-intervention value, within group. &#x002e0; p&#x0003c;0.05, pre to post change compared with change from pre to post in SED. Abbreviations used: KF, knee flexion; KE, knee extension.</p></caption><graphic xlink:href="pone.0133697.g003"/></fig></sec><sec id="sec025"><title>2. Endurance capacity</title><p>After 12 weeks, endurance capacity variables remained stable in SED and H<sub>CT</sub>R. Compared to SED and H<sub>CT</sub>R, W<sub>max</sub> (+21&#x000b1;4%, p = 0.0001), test duration (+24&#x000b1;5%, p = 0.00008) and VO<sub>2max</sub> (+17&#x000b1;5%, p = 0.001) significantly improved in H<sub>IT</sub>R (<xref rid="pone.0133697.t003" ref-type="table">Table 3</xref>).</p><table-wrap id="pone.0133697.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0133697.t003</object-id><label>Table 3</label><caption><title>Exercise capacity, body composition and physical activity level after 12 weeks of usual care or high intensity aerobic exercise in combination with resistance training.</title><p>Data are reported as mean &#x000b1; SE. Differences between groups (SED, H<sub>CT</sub>R and H<sub>IT</sub>R) were analysed by a one-way ANOVA, whereas within group differences (post minus pre) were analysed with a paired student&#x02019;s t-test. Relative changes due to the intervention were calculated as the mean of the individual changes and expressed as a percentage. Abbreviations used: SED, sedentary (usual care); H<sub>CT</sub>R, high intensity continuous exercise + resistance training; H<sub>IT</sub>R, high intensity interval training + resistance training; MET, metabolic equivalent.</p></caption><alternatives><graphic id="pone.0133697.t003g" xlink:href="pone.0133697.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th colspan="3" align="center" rowspan="1">SED</th><th colspan="3" align="center" rowspan="1">H<sub>CT</sub>R</th><th colspan="3" align="center" rowspan="1">H<sub>IT</sub>R</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Pre</th><th align="center" rowspan="1" colspan="1">Post</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">Pre</th><th align="center" rowspan="1" colspan="1">Post</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">Pre</th><th align="center" rowspan="1" colspan="1">Post</th><th align="center" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<underline><bold>Exercise capacity:</bold></underline>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Maximal cycling resistance (watt)</bold>
</td><td align="center" rowspan="1" colspan="1">121&#x000b1;8</td><td align="center" rowspan="1" colspan="1">115&#x000b1;11</td><td align="center" rowspan="1" colspan="1">
<bold>-4.6&#x000b1;2.7</bold>
</td><td align="center" rowspan="1" colspan="1">131&#x000b1;18</td><td align="center" rowspan="1" colspan="1">133&#x000b1;18</td><td align="center" rowspan="1" colspan="1">
<bold>3.6&#x000b1;2.8</bold>
</td><td align="center" rowspan="1" colspan="1">158&#x000b1;15</td><td align="center" rowspan="1" colspan="1">188&#x000b1;15<xref rid="t003fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>21.2&#x000b1;3.9</bold>
<xref rid="t003fn003" ref-type="table-fn">
<sup>c</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Maximal cycling resistance (watt/kg)</bold>
</td><td align="center" rowspan="1" colspan="1">1.6&#x000b1;0.12</td><td align="center" rowspan="1" colspan="1">1.6&#x000b1;0.15</td><td align="center" rowspan="1" colspan="1">
<bold>-4.6&#x000b1;2.7</bold>
</td><td align="center" rowspan="1" colspan="1">1.85&#x000b1;0.24</td><td align="center" rowspan="1" colspan="1">1.9&#x000b1;0.23</td><td align="center" rowspan="1" colspan="1">
<bold>3.6&#x000b1;2.8</bold>
</td><td align="center" rowspan="1" colspan="1">2.0&#x000b1;0.17</td><td align="center" rowspan="1" colspan="1">2.4&#x000b1;0.16<xref rid="t003fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>21.2&#x000b1;3.9</bold>
<xref rid="t003fn003" ref-type="table-fn">
<sup>c</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Test duration (min)</bold>
</td><td align="center" rowspan="1" colspan="1">10.4&#x000b1;0.8</td><td align="center" rowspan="1" colspan="1">9.9&#x000b1;0.8</td><td align="center" rowspan="1" colspan="1">
<bold>-3.1&#x000b1;2.9</bold>
</td><td align="center" rowspan="1" colspan="1">9.5&#x000b1;1.0</td><td align="center" rowspan="1" colspan="1">9.8&#x000b1;0.9</td><td align="center" rowspan="1" colspan="1">
<bold>5.2&#x000b1;3.1</bold>
</td><td align="center" rowspan="1" colspan="1">12.1&#x000b1;0.9</td><td align="center" rowspan="1" colspan="1">14.5&#x000b1;0.9<xref rid="t003fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>24.7&#x000b1;4.6</bold>
<xref rid="t003fn003" ref-type="table-fn">
<sup>c</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>VO</bold>
<sub><bold>2</bold></sub>
<bold>max (ml/min)</bold>
</td><td align="center" rowspan="1" colspan="1">1647&#x000b1;133</td><td align="center" rowspan="1" colspan="1">1645&#x000b1;160</td><td align="center" rowspan="1" colspan="1">
<bold>2.5&#x000b1;4.1</bold>
</td><td align="center" rowspan="1" colspan="1">1870&#x000b1;238</td><td align="center" rowspan="1" colspan="1">1969&#x000b1;230</td><td align="center" rowspan="1" colspan="1">
<bold>7.5&#x000b1;5.8</bold>
</td><td align="center" rowspan="1" colspan="1">2031&#x000b1;186</td><td align="center" rowspan="1" colspan="1">2379&#x000b1;197<xref rid="t003fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>17.8&#x000b1;4.6</bold>
<xref rid="t003fn003" ref-type="table-fn">
<sup>c</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>VO</bold>
<sub><bold>2</bold></sub>
<bold>max (ml/min/kg)</bold>
</td><td align="center" rowspan="1" colspan="1">21.9&#x000b1;1.8</td><td align="center" rowspan="1" colspan="1">23.6&#x000b1;2.1</td><td align="center" rowspan="1" colspan="1">
<bold>2.5&#x000b1;4.1</bold>
</td><td align="center" rowspan="1" colspan="1">26.3&#x000b1;3.1</td><td align="center" rowspan="1" colspan="1">28.2&#x000b1;3.0</td><td align="center" rowspan="1" colspan="1">
<bold>7.5&#x000b1;5.8</bold>
</td><td align="center" rowspan="1" colspan="1">26.6&#x000b1;2.2</td><td align="center" rowspan="1" colspan="1">30.7&#x000b1;2.1<xref rid="t003fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>17.8&#x000b1;4.6</bold>
<xref rid="t003fn003" ref-type="table-fn">
<sup>c</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Minute Ventilation (l/min)</bold>
</td><td align="center" rowspan="1" colspan="1">57&#x000b1;4</td><td align="center" rowspan="1" colspan="1">62&#x000b1;7</td><td align="center" rowspan="1" colspan="1">
<bold>9.9&#x000b1;6.5</bold>
</td><td align="center" rowspan="1" colspan="1">70&#x000b1;11</td><td align="center" rowspan="1" colspan="1">76&#x000b1;11<xref rid="t003fn002" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>13.3&#x000b1;7.7</bold>
</td><td align="center" rowspan="1" colspan="1">76&#x000b1;7</td><td align="center" rowspan="1" colspan="1">96&#x000b1;6<xref rid="t003fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>32.7&#x000b1;8.7</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Breathing frequency</bold>
</td><td align="center" rowspan="1" colspan="1">32&#x000b1;2</td><td align="center" rowspan="1" colspan="1">39&#x000b1;3<xref rid="t003fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>25.7&#x000b1;5.5</bold>
</td><td align="center" rowspan="1" colspan="1">32&#x000b1;2</td><td align="center" rowspan="1" colspan="1">37&#x000b1;2<xref rid="t003fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>14.3&#x000b1;4.6</bold>
</td><td align="center" rowspan="1" colspan="1">32&#x000b1;2</td><td align="center" rowspan="1" colspan="1">41&#x000b1;3<xref rid="t003fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>39.6&#x000b1;16.8</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Tidal Volume (ml)</bold>
</td><td align="center" rowspan="1" colspan="1">1789&#x000b1;138</td><td align="center" rowspan="1" colspan="1">1617&#x000b1;154</td><td align="center" rowspan="1" colspan="1">
<bold>-11.2&#x000b1;6.2</bold>
</td><td align="center" rowspan="1" colspan="1">2155&#x000b1;241</td><td align="center" rowspan="1" colspan="1">2086&#x000b1;287</td><td align="center" rowspan="1" colspan="1">
<bold>-1.2&#x000b1;4.6</bold>
</td><td align="center" rowspan="1" colspan="1">2394&#x000b1;190</td><td align="center" rowspan="1" colspan="1">2425&#x000b1;189</td><td align="center" rowspan="1" colspan="1">
<bold>-0.5&#x000b1;5.2</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>RER max</bold>
</td><td align="center" rowspan="1" colspan="1">1.18&#x000b1;0.04</td><td align="center" rowspan="1" colspan="1">1.17&#x000b1;0.03</td><td align="center" rowspan="1" colspan="1">
<bold>-3.2&#x000b1;2.8</bold>
</td><td align="center" rowspan="1" colspan="1">1.3&#x000b1;0.03</td><td align="center" rowspan="1" colspan="1">1.2&#x000b1;0.02</td><td align="center" rowspan="1" colspan="1">
<bold>-2.2&#x000b1;2.9</bold>
</td><td align="center" rowspan="1" colspan="1">1.2&#x000b1;0.03</td><td align="center" rowspan="1" colspan="1">1.2&#x000b1;0.02</td><td align="center" rowspan="1" colspan="1">
<bold>1.3&#x000b1;2.5</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>HR rest (beats/min)</bold>
</td><td align="center" rowspan="1" colspan="1">75&#x000b1;4</td><td align="center" rowspan="1" colspan="1">87&#x000b1;4<xref rid="t003fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>14.3&#x000b1;3.8</bold>
</td><td align="center" rowspan="1" colspan="1">76&#x000b1;3</td><td align="center" rowspan="1" colspan="1">80&#x000b1;4</td><td align="center" rowspan="1" colspan="1">
<bold>7.0&#x000b1;5.8</bold>
</td><td align="center" rowspan="1" colspan="1">75&#x000b1;3</td><td align="center" rowspan="1" colspan="1">84&#x000b1;3</td><td align="center" rowspan="1" colspan="1">
<bold>12.5&#x000b1;4.6</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>HR max (beats/min)</bold>
</td><td align="center" rowspan="1" colspan="1">142&#x000b1;7</td><td align="center" rowspan="1" colspan="1">153&#x000b1;5</td><td align="center" rowspan="1" colspan="1">
<bold>6.5&#x000b1;2.3</bold>
</td><td align="center" rowspan="1" colspan="1">154&#x000b1;6</td><td align="center" rowspan="1" colspan="1">162&#x000b1;6<xref rid="t003fn002" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>3.7&#x000b1;1.5</bold>
</td><td align="center" rowspan="1" colspan="1">160&#x000b1;6</td><td align="center" rowspan="1" colspan="1">168&#x000b1;5<xref rid="t003fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>6.2&#x000b1;2.2</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<underline><bold>Body composition:</bold></underline>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Lean tissue mass (kg)</bold>
</td><td align="center" rowspan="1" colspan="1">43.2&#x000b1;2.1</td><td align="center" rowspan="1" colspan="1">43.5&#x000b1;2.1</td><td align="center" rowspan="1" colspan="1">
<bold>0.6&#x000b1;0.6</bold>
</td><td align="center" rowspan="1" colspan="1">45.4&#x000b1;2.6</td><td align="center" rowspan="1" colspan="1">46.2&#x000b1;2.5</td><td align="center" rowspan="1" colspan="1">
<bold>0.9&#x000b1;0.9</bold>
</td><td align="center" rowspan="1" colspan="1">48.5&#x000b1;3.1</td><td align="center" rowspan="1" colspan="1">49.9&#x000b1;3.1<xref rid="t003fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>1.4&#x000b1;0.5</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Fat percentage (%)</bold>
</td><td align="center" rowspan="1" colspan="1">38.2&#x000b1;2.1</td><td align="center" rowspan="1" colspan="1">37.3&#x000b1;2.2</td><td align="center" rowspan="1" colspan="1">
<bold>-2.8&#x000b1;1.6</bold>
</td><td align="center" rowspan="1" colspan="1">33.6&#x000b1;2.8</td><td align="center" rowspan="1" colspan="1">32.6&#x000b1;2.8<xref rid="t003fn002" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>-2.5&#x000b1;1.2</bold>
</td><td align="center" rowspan="1" colspan="1">36.2&#x000b1;1.9</td><td align="center" rowspan="1" colspan="1">34.3&#x000b1;2.0<xref rid="t003fn002" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>-3.9&#x000b1;2.0</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<underline><bold>Physical activity level:</bold></underline>
<bold>(MET*h/week)</bold>
</td><td align="center" rowspan="1" colspan="1">16&#x000b1;2.6</td><td align="center" rowspan="1" colspan="1">15.8&#x000b1;3.7</td><td align="center" rowspan="1" colspan="1">
<bold>2.9&#x000b1;13</bold>
</td><td align="center" rowspan="1" colspan="1">14.7&#x000b1;2.7</td><td align="center" rowspan="1" colspan="1">23.9&#x000b1;4.4<xref rid="t003fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>73&#x000b1;19</bold>
<xref rid="t003fn003" ref-type="table-fn">
<sup>c</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">25.8&#x000b1;6.6</td><td align="center" rowspan="1" colspan="1">37.6&#x000b1;7.2<xref rid="t003fn001" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">
<bold>86&#x000b1;27</bold>
<xref rid="t003fn003" ref-type="table-fn">
<sup>c</sup>
</xref>
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>a p&#x0003c;0.01,</p></fn><fn id="t003fn002"><p>b p&#x0003c;0.05, compared with pre-intervention value, within group.</p></fn><fn id="t003fn003"><p>c p&#x0003c;0.01, pre to post change compared with change from pre to post in SED.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec026"><title>3. Body composition</title><p>Following 12 weeks of exercise, body weight remained stable in all groups (p&#x0003e;0.05). Within H<sub>IT</sub>R and H<sub>CT</sub>R, body fat percentage tended to decrease by 3.9&#x000b1;2.0% (p = 0.04) and 2.5&#x000b1;1.2% (p = 0.02), respectively. Furthermore, lean tissue mass significantly increased 1.4&#x000b1;0.5% within H<sub>IT</sub>R (p = 0.01), whereas it remained stable in H<sub>CT</sub>R and SED (p&#x0003e;0.05, <xref rid="pone.0133697.t003" ref-type="table">Table 3</xref>). Finally, other adipose and lean tissue mass indices remained stable in all groups (p&#x0003e;0.05).</p></sec><sec id="sec027"><title>4. Physical activity level</title><p>Compared to SED, the physical activity level of H<sub>IT</sub>R and H<sub>CT</sub>R significantly increased by 86&#x000b1;27% (p = 0.004) and 73&#x000b1;19% (p = 0.003), respectively, following 12 weeks of exercise. In SED the physical activity level remained stable (<xref rid="pone.0133697.t003" ref-type="table">Table 3</xref>).</p></sec></sec><sec id="sec028"><title>Correlations</title><p>Overall, no significant correlations were found between the change of the primary and secondary outcome measures on pooled data.</p></sec></sec><sec sec-type="conclusions" id="sec029"><title>Discussion</title><p>This study is the first to investigate the impact of high intensity cardiovascular exercise combined with resistance training on muscle contractile characteristics and endurance capacity in MS. Moreover, 12 weeks of the applied high intensity programs were safe, well tolerated and induced beneficial adaptations in MS patients. In particular, muscle fiber CSA, muscle strength of the weaker legs and self-reported physical activity levels improved following both H<sub>IT</sub>R and H<sub>CT</sub>R. In addition, further improvements of the endurance capacity, muscle flexion strength of the stronger legs and lean tissue mass were only seen in H<sub>IT</sub>R. These results are clinically relevant, due to the need for exercise programs that are able to counteract reduced endurance capacity, muscle strength and muscle mass of particularly the lower limbs, enhancing physical function in MS patients.</p><sec id="sec030"><title>Safety and tolerability</title><p>Several studies have already demonstrated the benefits of resistance training [<xref rid="pone.0133697.ref006" ref-type="bibr">6</xref>] or endurance training [<xref rid="pone.0133697.ref007" ref-type="bibr">7</xref>&#x02013;<xref rid="pone.0133697.ref009" ref-type="bibr">9</xref>] in MS. The effect of combined training has only been sparsely explored [<xref rid="pone.0133697.ref011" ref-type="bibr">11</xref>&#x02013;<xref rid="pone.0133697.ref014" ref-type="bibr">14</xref>] and the impact of high intensity combined exercise has never been investigated before. The latter could be explained by safety concerns regarding the symptom instability of MS patients often seen during/after high intensity exercise, which is frequently caused by the exercise-induced increase in body temperature [<xref rid="pone.0133697.ref030" ref-type="bibr">30</xref>]. Interestingly, no dropout or adverse events were reported during and after 12 weeks of H<sub>IT</sub>R and H<sub>CT</sub>R, demonstrating that mild-to-moderately impaired MS patients tolerate intense exercise programs.</p></sec><sec id="sec031"><title>Continuous vs. interval training</title><p>The present study showed an improvement of the endurance capacity, muscle flexion strength of the stronger legs and lean tissue mass in H<sub>IT</sub>R, and improved muscle strength of the weaker leg and self-reported physical activity levels in H<sub>IT</sub>R and H<sub>CT</sub>R, suggesting that exercise efficiency is even higher in H<sub>IT</sub>R. This is in line with literature in other patient populations, investigating the difference between continue and interval training, stating that exercise intensity is an important factor to improve, amongst others, cardiorespiratory fitness [<xref rid="pone.0133697.ref031" ref-type="bibr">31</xref>&#x02013;<xref rid="pone.0133697.ref033" ref-type="bibr">33</xref>], but also arterial stiffness [<xref rid="pone.0133697.ref034" ref-type="bibr">34</xref>] and hypertension [<xref rid="pone.0133697.ref035" ref-type="bibr">35</xref>]. In general, the magnitude of improvements was greater after high intensity interval training. Importantly, and as already suggested by others [<xref rid="pone.0133697.ref010" ref-type="bibr">10</xref>], the observed training improvements in the present study were often larger compared to those reported after mild-to-moderate combined exercise programs in MS patients [<xref rid="pone.0133697.ref011" ref-type="bibr">11</xref>&#x02013;<xref rid="pone.0133697.ref015" ref-type="bibr">15</xref>]. This suggests that higher training intensities are more effective and that training adaptations are intensity related in MS.</p><p>Interestingly, the maximal heart rate changed from baseline to post training in H<sub>IT</sub>R. This can possibly be explained due to the fact that these patients might have impaired chronotropic regulation at baseline, which can broadly be defined as the inability of the heart to increase its rate commensurate with increased activity or demand, which might be induced by cardiac autonomic dysfunction, as already reported by our research group [<xref rid="pone.0133697.ref036" ref-type="bibr">36</xref>,<xref rid="pone.0133697.ref037" ref-type="bibr">37</xref>]. In other populations, exercise is able to increase peak heart rate and to reverse, at least partially, impaired chronotropic regulation [<xref rid="pone.0133697.ref038" ref-type="bibr">38</xref>&#x02013;<xref rid="pone.0133697.ref042" ref-type="bibr">42</xref>], which contribute to the exercise-induced increase in exercise capacity and other outcome measures. Since this was only seen in H<sub>IT</sub>R and not in H<sub>CT</sub>R, it suggests again that higher training intensities might be more effective in MS. Nevertheless, impaired chronotropic regulation was never investigated into depth in MS patients and warrants further research in the future.</p></sec><sec id="sec032"><title>Muscular effects</title><p>Recently, we reported that MS affects muscle fiber CSA and proportion [<xref rid="pone.0133697.ref023" ref-type="bibr">23</xref>]. To our knowledge, only Dalgas et al. investigated the effects of exercise (progressive resistance training) on muscle fiber CSA in MS [<xref rid="pone.0133697.ref024" ref-type="bibr">24</xref>], reporting increased mean muscle fiber CSA (8&#x000b1;15%), predominantly in type II muscle fiber CSA (14&#x000b1;19%) and a tendency towards increased type I CSA [<xref rid="pone.0133697.ref024" ref-type="bibr">24</xref>]. In the present study, mean muscle fiber CSA (H<sub>IT</sub>R: 21&#x000b1;7%, H<sub>CT</sub>R: 23&#x000b1;5%) and lean muscle mass further increased, suggesting an additional value of the high intensity aerobic exercise. This is, partly, in accordance with results reported in sedentary HC, demonstrating a significant increase of the area of type I and IIx fibers after high intensity interval training [<xref rid="pone.0133697.ref043" ref-type="bibr">43</xref>]. In addition, high intensity aerobic exercise induced an increased CSA of both type IIa and IIx fibers and no changes in type I fiber size in elite ice hockey players [<xref rid="pone.0133697.ref044" ref-type="bibr">44</xref>].</p><p>Based on an often more inactive lifestyle of MS patients, Dalgas et al. expected an inactivity-related higher proportion of type IIx fibers and a possibility to transform type IIx to IIa fibers after progressive resistance training [<xref rid="pone.0133697.ref045" ref-type="bibr">45</xref>,<xref rid="pone.0133697.ref046" ref-type="bibr">46</xref>]. However, they were not able to report any changes in the proportion of fiber types. In the present study, type IIx proportions decreased after 12 weeks of H<sub>CT</sub>R, whereas the type I proportion tended to increase in H<sub>CT</sub>R and H<sub>IT</sub>R. These results are comparable with data reported in healthy elderly populations, reporting a reduction of the type IIx proportion and an increase of the proportion of the type IIa fibers [<xref rid="pone.0133697.ref047" ref-type="bibr">47</xref>,<xref rid="pone.0133697.ref048" ref-type="bibr">48</xref>]. Interestingly, these studies used higher training frequencies [<xref rid="pone.0133697.ref047" ref-type="bibr">47</xref>] or longer training periods [<xref rid="pone.0133697.ref048" ref-type="bibr">48</xref>], compared to the work of Dalgas et al. [<xref rid="pone.0133697.ref024" ref-type="bibr">24</xref>], suggesting that a higher training volume and intensity is required to induce fiber type changes than to induce changes in fiber type CSA.</p></sec><sec id="sec033"><title>Limitations</title><p>Since this is the first study that investigated the effects of high intensity exercise on muscle fiber CSA and proportion in MS, we were not able to perform a pre-trial power analysis, due to the absence of a defined effect size. Nevertheless, a post-hoc power analysis (R 2.15.2 software) on mean muscle fiber CSA and based on the present results, demonstrated that 5 persons in each group would be sufficient to provide a &#x0003e;80% power to detect a 20% increase of mean muscle fiber CSA after 12 weeks of high intensity exercise (p = 0.05, &#x003c3; = 7%), demonstrating a suitable sample size in the present study. Secondly, given the ethical concerns we collected only one biopsy per test, despite the recommendation of Lexell et al. [<xref rid="pone.0133697.ref049" ref-type="bibr">49</xref>] to optimally collect three biopsies from different depths of the muscle and to analyse &#x0003e;150 fibers from each sample to reduce sampling error. Furthermore, since self-reported physical activity measures are not perfect measures, we propose the use of accelerometers in future studies. Also the inclusion of a follow up examination, to determine whether the improvements are long lasting, could be recommended in future studies. Finally, given the nature of the design, social interactions between MS patients could possibly influence intervention outcomes.</p></sec></sec><sec sec-type="conclusions" id="sec034"><title>Conclusion</title><p>The present study showed that 12 weeks of high intensity cardiovascular exercise in combination with resistance training was safe, well tolerated and improved muscle contractile characteristics and endurance capacity, with interval training seemingly superior to continuous training.</p></sec><sec sec-type="supplementary-material" id="sec035"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0133697.s001"><label>S1 CONSORT Checklist</label><caption><title>CONSORT Checklist.</title><p>(DOC)</p></caption><media xlink:href="pone.0133697.s001.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0133697.s002"><label>S1 Protocol</label><caption><title>Trial Protocol.</title><p>(DOCX)</p></caption><media xlink:href="pone.0133697.s002.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank all MS patients for participating in this study. Our gratitude goes to prof. dr. Niel Hens (Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Hasselt University, Belgium and Centre for Health Economics Research &#x00026; Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Belgium) for statistical advise and discussion, to prof. dr. Bart Van Wijmeersch (Rehabilitation and MS Center, Overpelt, Belgium) for the recruitment and medical examination of all patients and to Devid Muys, without whose help and support this study would not have been possible.</p></ack><ref-list><title>References</title><ref id="pone.0133697.ref001"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Stuifbergen</surname><given-names>AK</given-names></name> (<year>1997</year>) <article-title>Physical activity and perceived health status in persons with multiple sclerosis</article-title>. <source>J Neurosci Nurs</source>
<volume>29</volume>: <fpage>238</fpage>&#x02013;<lpage>243</lpage>.
<pub-id pub-id-type="pmid">9307926</pub-id></mixed-citation></ref><ref id="pone.0133697.ref002"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Compston</surname><given-names>A</given-names></name>, <name><surname>Coles</surname><given-names>A</given-names></name> (<year>2002</year>) <article-title>Multiple sclerosis</article-title>. <source>Lancet</source>
<volume>359</volume>: <fpage>1221</fpage>&#x02013;<lpage>1231</lpage>.
<pub-id pub-id-type="pmid">11955556</pub-id></mixed-citation></ref><ref id="pone.0133697.ref003"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Motl</surname><given-names>RW</given-names></name>, <name><surname>Gosney</surname><given-names>JL</given-names></name> (<year>2008</year>) <article-title>Effect of exercise training on quality of life in multiple sclerosis: a meta-analysis</article-title>. <source>Mult Scler</source>
<volume>14</volume>: <fpage>129</fpage>&#x02013;<lpage>135</lpage>.
<pub-id pub-id-type="pmid">17881388</pub-id></mixed-citation></ref><ref id="pone.0133697.ref004"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Motl</surname><given-names>RW</given-names></name>, <name><surname>Snook</surname><given-names>EM</given-names></name>, <name><surname>Wynn</surname><given-names>DR</given-names></name>, <name><surname>Vollmer</surname><given-names>T</given-names></name> (<year>2008</year>) <article-title>Physical activity correlates with neurological impairment and disability in multiple sclerosis</article-title>. <source>J Nerv Ment Dis</source>
<volume>196</volume>: <fpage>492</fpage>&#x02013;<lpage>495</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/NMD.0b013e318177351b">10.1097/NMD.0b013e318177351b</ext-link></comment>
<pub-id pub-id-type="pmid">18552627</pub-id></mixed-citation></ref><ref id="pone.0133697.ref005"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Stuifbergen</surname><given-names>AK</given-names></name>, <name><surname>Blozis</surname><given-names>SA</given-names></name>, <name><surname>Harrison</surname><given-names>TC</given-names></name>, <name><surname>Becker</surname><given-names>HA</given-names></name> (<year>2006</year>) <article-title>Exercise, Functional Limitations, and Quality of Life: A Longitudinal Study of Persons With Multiple Sclerosis</article-title>. <source>Archives of Physical Medicine and Rehabilitation</source>
<volume>87</volume>: <fpage>935</fpage>&#x02013;<lpage>943</lpage>.
<pub-id pub-id-type="pmid">16813781</pub-id></mixed-citation></ref><ref id="pone.0133697.ref006"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Kjolhede</surname><given-names>T</given-names></name>, <name><surname>Vissing</surname><given-names>K</given-names></name>, <name><surname>Dalgas</surname><given-names>U</given-names></name> (<year>2012</year>) <article-title>Multiple sclerosis and progressive resistance training: a systematic review</article-title>. <source>Mult Scler</source>
<volume>18</volume>: <fpage>1215</fpage>&#x02013;<lpage>1228</lpage>. 1352458512437418 [pii];<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/1352458512437418">10.1177/1352458512437418</ext-link></comment>
<pub-id pub-id-type="pmid">22760230</pub-id></mixed-citation></ref><ref id="pone.0133697.ref007"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Petajan</surname><given-names>JH</given-names></name>, <name><surname>Gappmaier</surname><given-names>E</given-names></name>, <name><surname>White</surname><given-names>AT</given-names></name>, <name><surname>Spencer</surname><given-names>MK</given-names></name>, <name><surname>Mino</surname><given-names>L</given-names></name>, <name><surname>Hicks</surname><given-names>RW</given-names></name> (<year>1996</year>) <article-title>Impact of aerobic training on fitness and quality of life in multiple sclerosis</article-title>. <source>Ann Neurol</source>
<volume>39</volume>: <fpage>432</fpage>&#x02013;<lpage>441</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ana.410390405">10.1002/ana.410390405</ext-link></comment>
<pub-id pub-id-type="pmid">8619521</pub-id></mixed-citation></ref><ref id="pone.0133697.ref008"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Schulz</surname><given-names>KH</given-names></name>, <name><surname>Gold</surname><given-names>SM</given-names></name>, <name><surname>Witte</surname><given-names>J</given-names></name>, <name><surname>Bartsch</surname><given-names>K</given-names></name>, <name><surname>Lang</surname><given-names>UE</given-names></name>, <name><surname>Hellweg</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis</article-title>. <source>J Neurol Sci</source>
<volume>225</volume>: <fpage>11</fpage>&#x02013;<lpage>18</lpage>.
<pub-id pub-id-type="pmid">15465080</pub-id></mixed-citation></ref><ref id="pone.0133697.ref009"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Dettmers</surname><given-names>C</given-names></name>, <name><surname>Sulzmann</surname><given-names>M</given-names></name>, <name><surname>Ruchay-Plossl</surname><given-names>A</given-names></name>, <name><surname>Gutler</surname><given-names>R</given-names></name>, <name><surname>Vieten</surname><given-names>M</given-names></name> (<year>2009</year>) <article-title>Endurance exercise improves walking distance in MS patients with fatigue</article-title>. <source>Acta Neurol Scand</source>
<volume>120</volume>: <fpage>251</fpage>&#x02013;<lpage>257</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1600-0404.2008.01152.x">10.1111/j.1600-0404.2008.01152.x</ext-link></comment>
<pub-id pub-id-type="pmid">19178385</pub-id></mixed-citation></ref><ref id="pone.0133697.ref010"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Dalgas</surname><given-names>U</given-names></name>, <name><surname>Stenager</surname><given-names>E</given-names></name>, <name><surname>Ingemann-Hansen</surname><given-names>T</given-names></name> (<year>2008</year>) <article-title>Multiple sclerosis and physical exercise: recommendations for the application of resistance-, endurance- and combined training</article-title>. <source>Mult Scler</source>
<volume>14</volume>: <fpage>35</fpage>&#x02013;<lpage>53</lpage>.
<pub-id pub-id-type="pmid">17881393</pub-id></mixed-citation></ref><ref id="pone.0133697.ref011"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Wens</surname><given-names>I</given-names></name>, <name><surname>Hansen</surname><given-names>D</given-names></name>, <name><surname>Eijnde</surname><given-names>BO</given-names></name> (<year>2012</year>) <article-title>The impact of 24 weeks of combined cardiovascular and strength training on glucose tolerance, muscle strength and aerobic capacity in persons with multiple sclerosis</article-title>. <source>Mult Scler</source>
<volume>18</volume>: <fpage>S35</fpage>&#x02013;<lpage>S37</lpage>.</mixed-citation></ref><ref id="pone.0133697.ref012"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Romberg</surname><given-names>A</given-names></name>, <name><surname>Virtanen</surname><given-names>A</given-names></name>, <name><surname>Ruutiainen</surname><given-names>J</given-names></name>, <name><surname>Aunola</surname><given-names>S</given-names></name>, <name><surname>Karppi</surname><given-names>SL</given-names></name>, <name><surname>Vaara</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Effects of a 6-month exercise program on patients with multiple sclerosis: A randomized study</article-title>. <source>Neurology</source>
<volume>63</volume>: <fpage>2034</fpage>&#x02013;<lpage>2038</lpage>.
<pub-id pub-id-type="pmid">15596746</pub-id></mixed-citation></ref><ref id="pone.0133697.ref013"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Surakka</surname><given-names>J</given-names></name>, <name><surname>Romberg</surname><given-names>A</given-names></name>, <name><surname>Ruutiainen</surname><given-names>J</given-names></name>, <name><surname>Aunola</surname><given-names>S</given-names></name>, <name><surname>Virtanen</surname><given-names>A</given-names></name>, <name><surname>Karppi</surname><given-names>SL</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Effects of aerobic and strength exercise on motor fatigue in men and women with multiple sclerosis: a randomized controlled trial</article-title>. <source>Clin Rehabil</source>
<volume>18</volume>: <fpage>737</fpage>&#x02013;<lpage>746</lpage>.
<pub-id pub-id-type="pmid">15573829</pub-id></mixed-citation></ref><ref id="pone.0133697.ref014"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Motl</surname><given-names>RW</given-names></name>, <name><surname>Smith</surname><given-names>DC</given-names></name>, <name><surname>Elliott</surname><given-names>J</given-names></name>, <name><surname>Weikert</surname><given-names>M</given-names></name>, <name><surname>Dlugonski</surname><given-names>D</given-names></name>, <name><surname>Sosnoff</surname><given-names>JJ</given-names></name> (<year>2012</year>) <article-title>Combined training improves walking mobility in persons with significant disability from multiple sclerosis: a pilot study</article-title>. <source>J Neurol Phys Ther</source>
<volume>36</volume>: <fpage>32</fpage>&#x02013;<lpage>37</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/NPT.0b013e3182477c92">10.1097/NPT.0b013e3182477c92</ext-link></comment>
<pub-id pub-id-type="pmid">22333922</pub-id></mixed-citation></ref><ref id="pone.0133697.ref015"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Wens</surname><given-names>I</given-names></name>, <name><surname>Hansen</surname><given-names>D</given-names></name>, <name><surname>Verboven</surname><given-names>K</given-names></name>, <name><surname>Deckx</surname><given-names>N</given-names></name>, <name><surname>Kosten</surname><given-names>L</given-names></name>, <name><surname>Stevens</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>The impact of 24 weeks resistance and endurance exercise on glucose tolerance in persons with multiple sclerosis</article-title>. <source>Am J Phys Med Rehabil</source> epub ahead of print.</mixed-citation></ref><ref id="pone.0133697.ref016"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Dalgas</surname><given-names>U</given-names></name>, <name><surname>Ingemann-Hansen</surname><given-names>T</given-names></name>, <name><surname>Stenager</surname><given-names>E</given-names></name> (<year>2009</year>) <article-title>Physical Exercise and MS Recommendations</article-title>. <source>Int MS J</source>
<volume>16</volume>: <fpage>5</fpage>&#x02013;<lpage>11</lpage>.
<pub-id pub-id-type="pmid">19413920</pub-id></mixed-citation></ref><ref id="pone.0133697.ref017"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Collett</surname><given-names>J</given-names></name>, <name><surname>Dawes</surname><given-names>H</given-names></name>, <name><surname>Meaney</surname><given-names>A</given-names></name>, <name><surname>Sackley</surname><given-names>C</given-names></name>, <name><surname>Barker</surname><given-names>K</given-names></name>, <name><surname>Wade</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Exercise for multiple sclerosis: a single-blind randomized trial comparing three exercise intensities</article-title>. <source>Mult Scler</source>.</mixed-citation></ref><ref id="pone.0133697.ref018"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Sloth</surname><given-names>M</given-names></name>, <name><surname>Sloth</surname><given-names>D</given-names></name>, <name><surname>Overgaard</surname><given-names>K</given-names></name>, <name><surname>Dalgas</surname><given-names>U</given-names></name> (<year>2013</year>) <article-title>Effects of sprint interval training on VO and aerobic exercise performance: A systematic review and meta-analysis</article-title>. <source>Scand J Med Sci Sports</source>
<volume>23</volume>: <fpage>e341</fpage>&#x02013;<lpage>e352</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/sms.12092">10.1111/sms.12092</ext-link></comment>
<pub-id pub-id-type="pmid">23889316</pub-id></mixed-citation></ref><ref id="pone.0133697.ref019"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Raymond</surname><given-names>MJ</given-names></name>, <name><surname>Bramley-Tzerefos</surname><given-names>RE</given-names></name>, <name><surname>Jeffs</surname><given-names>KJ</given-names></name>, <name><surname>Winter</surname><given-names>A</given-names></name>, <name><surname>Holland</surname><given-names>AE</given-names></name> (<year>2013</year>) <article-title>Systematic review of high-intensity progressive resistance strength training of the lower limb compared with other intensities of strength training in older adults</article-title>. <source>Arch Phys Med Rehabil</source>
<volume>94</volume>: <fpage>1458</fpage>&#x02013;<lpage>1472</lpage>. S0003-9993(13)00201-3 [pii];<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.apmr.2013.02.022">10.1016/j.apmr.2013.02.022</ext-link></comment>
<pub-id pub-id-type="pmid">23473702</pub-id></mixed-citation></ref><ref id="pone.0133697.ref020"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Boutcher</surname><given-names>SH</given-names></name> (<year>2011</year>) <article-title>High-intensity intermittent exercise and fat loss</article-title>. <source>J Obes</source>
<volume>2011</volume>: <fpage>868305</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1155/2011/868305">10.1155/2011/868305</ext-link></comment>
<pub-id pub-id-type="pmid">21113312</pub-id></mixed-citation></ref><ref id="pone.0133697.ref021"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Boyne</surname><given-names>P</given-names></name>, <name><surname>Dunning</surname><given-names>K</given-names></name>, <name><surname>Carl</surname><given-names>D</given-names></name>, <name><surname>Gerson</surname><given-names>M</given-names></name>, <name><surname>Khoury</surname><given-names>J</given-names></name>, <name><surname>Kissela</surname><given-names>B</given-names></name> (<year>2013</year>) <article-title>High-intensity interval training in stroke rehabilitation</article-title>. <source>Top Stroke Rehabil</source>
<volume>20</volume>: <fpage>317</fpage>&#x02013;<lpage>330</lpage>. 84K65632217XP8K4 [pii];<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1310/tsr2004-317">10.1310/tsr2004-317</ext-link></comment>
<pub-id pub-id-type="pmid">23893831</pub-id></mixed-citation></ref><ref id="pone.0133697.ref022"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Kemi</surname><given-names>OJ</given-names></name>, <name><surname>Wisloff</surname><given-names>U</given-names></name> (<year>2010</year>) <article-title>High-intensity aerobic exercise training improves the heart in health and disease</article-title>. <source>J Cardiopulm Rehabil Prev</source>
<volume>30</volume>: <fpage>2</fpage>&#x02013;<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/HCR.0b013e3181c56b89">10.1097/HCR.0b013e3181c56b89</ext-link></comment>
<pub-id pub-id-type="pmid">20040880</pub-id></mixed-citation></ref><ref id="pone.0133697.ref023"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Wens</surname><given-names>I</given-names></name>, <name><surname>Dalgas</surname><given-names>U</given-names></name>, <name><surname>Vandenabeele</surname><given-names>F</given-names></name>, <name><surname>Krekels</surname><given-names>M</given-names></name>, <name><surname>Grevendonk</surname><given-names>L</given-names></name>, <name><surname>Eijnde</surname><given-names>BO</given-names></name> (<year>2014</year>) <article-title>Multiple sclerosis affects skeletal muscle characteristics</article-title>. <source>PLoS One</source>
<volume>9</volume>: <fpage>e108158</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0108158">10.1371/journal.pone.0108158</ext-link></comment>;PONE-D-14-19881 [pii].
<pub-id pub-id-type="pmid">25264868</pub-id></mixed-citation></ref><ref id="pone.0133697.ref024"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Dalgas</surname><given-names>U</given-names></name>, <name><surname>Stenager</surname><given-names>E</given-names></name>, <name><surname>Jakobsen</surname><given-names>J</given-names></name>, <name><surname>Petersen</surname><given-names>T</given-names></name>, <name><surname>Overgaard</surname><given-names>K</given-names></name>, <name><surname>Ingemann-Hansen</surname><given-names>T</given-names></name> (<year>2010</year>) <article-title>Muscle fiber size increases following resistance training in multiple sclerosis</article-title>. <source>Mult Scler</source>.</mixed-citation></ref><ref id="pone.0133697.ref025"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Thoumie</surname><given-names>P</given-names></name>, <name><surname>Lamotte</surname><given-names>D</given-names></name>, <name><surname>Cantalloube</surname><given-names>S</given-names></name>, <name><surname>Faucher</surname><given-names>M</given-names></name>, <name><surname>Amarenco</surname><given-names>G</given-names></name> (<year>2005</year>) <article-title>Motor determinants of gait in 100 ambulatory patients with multiple sclerosis</article-title>. <source>Multiple Sclerosis</source>
<volume>11</volume>: <fpage>485</fpage>&#x02013;<lpage>491</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1191/1352458505ms1176oa">10.1191/1352458505ms1176oa</ext-link></comment>
<pub-id pub-id-type="pmid">16042234</pub-id></mixed-citation></ref><ref id="pone.0133697.ref026"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Brooke</surname><given-names>MH</given-names></name>, <name><surname>Kaiser</surname><given-names>KK</given-names></name> (<year>1970</year>) <article-title>Muscle fiber types: how many and what kind?</article-title>
<source>Arch Neurol</source>
<volume>23</volume>: <fpage>369</fpage>&#x02013;<lpage>379</lpage>.
<pub-id pub-id-type="pmid">4248905</pub-id></mixed-citation></ref><ref id="pone.0133697.ref027"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Broekmans</surname><given-names>T</given-names></name>, <name><surname>Roelants</surname><given-names>M</given-names></name>, <name><surname>Feys</surname><given-names>P</given-names></name>, <name><surname>Alders</surname><given-names>G</given-names></name>, <name><surname>Gijbels</surname><given-names>D</given-names></name>, <name><surname>Hanssen</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Effects of long-term resistance training and simultaneous electro-stimulation on muscle strength and functional mobility in multiple sclerosis</article-title>. <source>Mult Scler</source>
<volume>17</volume>: <fpage>468</fpage>&#x02013;<lpage>477</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/1352458510391339">10.1177/1352458510391339</ext-link></comment>
<pub-id pub-id-type="pmid">21148266</pub-id></mixed-citation></ref><ref id="pone.0133697.ref028"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Langeskov-Christensen</surname><given-names>M</given-names></name>, <name><surname>Langeskov-Christensen</surname><given-names>D</given-names></name>, <name><surname>Overgaard</surname><given-names>K</given-names></name>, <name><surname>Moller</surname><given-names>AB</given-names></name>, <name><surname>Dalgas</surname><given-names>U</given-names></name> (<year>2014</year>) <article-title>Validity and reliability of VO(2)-max measurements in persons with multiple sclerosis</article-title>. <source>J Neurol Sci</source>
<volume>342</volume>: <fpage>79</fpage>&#x02013;<lpage>87</lpage>. S0022-510X(14)00249-4 [pii];<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jns.2014.04.028">10.1016/j.jns.2014.04.028</ext-link></comment>
<pub-id pub-id-type="pmid">24825731</pub-id></mixed-citation></ref><ref id="pone.0133697.ref029"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Washburn</surname><given-names>RA</given-names></name>, <name><surname>Zhu</surname><given-names>W</given-names></name>, <name><surname>McAuley</surname><given-names>E</given-names></name>, <name><surname>Frogley</surname><given-names>M</given-names></name>, <name><surname>Figoni</surname><given-names>SF</given-names></name> (<year>2002</year>) <article-title>The physical activity scale for individuals with physical disabilities: development and evaluation</article-title>. <source>Arch Phys Med Rehabil</source>
<volume>83</volume>: <fpage>193</fpage>&#x02013;<lpage>200</lpage>. S0003999302323773 [pii].
<pub-id pub-id-type="pmid">11833022</pub-id></mixed-citation></ref><ref id="pone.0133697.ref030"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Smith</surname><given-names>RM</given-names></name>, <name><surname>Adeney-Steel</surname><given-names>M</given-names></name>, <name><surname>Fulcher</surname><given-names>G</given-names></name>, <name><surname>Longley</surname><given-names>WA</given-names></name> (<year>2006</year>) <article-title>Symptom change with exercise is a temporary phenomenon for people with multiple sclerosis</article-title>. <source>Arch Phys Med Rehabil</source>
<volume>87</volume>: <fpage>723</fpage>&#x02013;<lpage>727</lpage>.
<pub-id pub-id-type="pmid">16635637</pub-id></mixed-citation></ref><ref id="pone.0133697.ref031"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Mitranun</surname><given-names>W</given-names></name>, <name><surname>Deerochanawong</surname><given-names>C</given-names></name>, <name><surname>Tanaka</surname><given-names>H</given-names></name>, <name><surname>Suksom</surname><given-names>D</given-names></name> (<year>2013</year>) <article-title>Continuous vs interval training on glycemic control and macro- and microvascular reactivity in type 2 diabetic patients</article-title>. <source>Scand J Med Sci Sports</source>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/sms.12112">10.1111/sms.12112</ext-link></comment>
<pub-id pub-id-type="pmid">24102912</pub-id></mixed-citation></ref><ref id="pone.0133697.ref032"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Tjonna</surname><given-names>AE</given-names></name>, <name><surname>Lee</surname><given-names>SJ</given-names></name>, <name><surname>Rognmo</surname><given-names>O</given-names></name>, <name><surname>Stolen</surname><given-names>TO</given-names></name>, <name><surname>Bye</surname><given-names>A</given-names></name>, <name><surname>Haram</surname><given-names>PM</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study</article-title>. <source>Circulation</source>
<volume>118</volume>: <fpage>346</fpage>&#x02013;<lpage>354</lpage>. CIRCULATIONAHA.108.772822 [pii];<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/CIRCULATIONAHA.108.772822">10.1161/CIRCULATIONAHA.108.772822</ext-link></comment>
<pub-id pub-id-type="pmid">18606913</pub-id></mixed-citation></ref><ref id="pone.0133697.ref033"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Ciolac</surname><given-names>EG</given-names></name>, <name><surname>Bocchi</surname><given-names>EA</given-names></name>, <name><surname>Bortolotto</surname><given-names>LA</given-names></name>, <name><surname>Carvalho</surname><given-names>VO</given-names></name>, <name><surname>Greve</surname><given-names>JM</given-names></name>, <name><surname>Guimaraes</surname><given-names>GV</given-names></name> (<year>2010</year>) <article-title>Effects of high-intensity aerobic interval training vs. moderate exercise on hemodynamic, metabolic and neuro-humoral abnormalities of young normotensive women at high familial risk for hypertension</article-title>. <source>Hypertens Res</source>
<volume>33</volume>: <fpage>836</fpage>&#x02013;<lpage>843</lpage>. hr201072 [pii];<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/hr.2010.72">10.1038/hr.2010.72</ext-link></comment>
<pub-id pub-id-type="pmid">20448634</pub-id></mixed-citation></ref><ref id="pone.0133697.ref034"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Guimaraes</surname><given-names>GV</given-names></name>, <name><surname>Ciolac</surname><given-names>EG</given-names></name>, <name><surname>Carvalho</surname><given-names>VO</given-names></name>, <name><surname>D'Avila</surname><given-names>VM</given-names></name>, <name><surname>Bortolotto</surname><given-names>LA</given-names></name>, <name><surname>Bocchi</surname><given-names>EA</given-names></name> (<year>2010</year>) <article-title>Effects of continuous vs. interval exercise training on blood pressure and arterial stiffness in treated hypertension</article-title>. <source>Hypertens Res</source>
<volume>33</volume>: <fpage>627</fpage>&#x02013;<lpage>632</lpage>. hr201042 [pii];<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/hr.2010.42">10.1038/hr.2010.42</ext-link></comment>
<pub-id pub-id-type="pmid">20379194</pub-id></mixed-citation></ref><ref id="pone.0133697.ref035"><label>35</label><mixed-citation publication-type="journal">
<name><surname>Ciolac</surname><given-names>EG</given-names></name> (<year>2012</year>) <article-title>High-intensity interval training and hypertension: maximizing the benefits of exercise?</article-title>
<source>Am J Cardiovasc Dis</source>
<volume>2</volume>: <fpage>102</fpage>&#x02013;<lpage>110</lpage>.
<pub-id pub-id-type="pmid">22720199</pub-id></mixed-citation></ref><ref id="pone.0133697.ref036"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Hansen</surname><given-names>D</given-names></name>, <name><surname>Wens</surname><given-names>I</given-names></name>, <name><surname>Dendale</surname><given-names>P</given-names></name>, <name><surname>Eijnde</surname><given-names>BO</given-names></name> (<year>2013</year>) <article-title>Exercise-onset heart rate increase is slowed in multiple sclerosis patients: does a disturbed cardiac autonomic control affect exercise tolerance?</article-title>
<source>NeuroRehabilitation</source>
<volume>33</volume>: <fpage>139</fpage>&#x02013;<lpage>146</lpage>. 40N14553GG00TK54 [pii];<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3233/NRE-130938">10.3233/NRE-130938</ext-link></comment>
<pub-id pub-id-type="pmid">23949040</pub-id></mixed-citation></ref><ref id="pone.0133697.ref037"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Hansen</surname><given-names>D</given-names></name>, <name><surname>Wens</surname><given-names>I</given-names></name>, <name><surname>Keytsman</surname><given-names>C</given-names></name>, <name><surname>Eijnde</surname><given-names>BO</given-names></name>, <name><surname>Dendale</surname><given-names>P</given-names></name> (<year>2014</year>) <article-title>Is long-term exercise intervention effective to improve cardiac autonomic control during exercise in subjects with multiple sclerosis? A randomized controlled trial</article-title>. <source>Eur J Phys Rehabil Med</source>. R33Y9999N00A140300 [pii].</mixed-citation></ref><ref id="pone.0133697.ref038"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Brubaker</surname><given-names>PH</given-names></name>, <name><surname>Kitzman</surname><given-names>DW</given-names></name> (<year>2011</year>) <article-title>Chronotropic incompetence: causes, consequences, and management</article-title>. <source>Circulation</source>
<volume>123</volume>: <fpage>1010</fpage>&#x02013;<lpage>1020</lpage>. 123/9/1010 [pii];<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/CIRCULATIONAHA.110.940577">10.1161/CIRCULATIONAHA.110.940577</ext-link></comment>
<pub-id pub-id-type="pmid">21382903</pub-id></mixed-citation></ref><ref id="pone.0133697.ref039"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Brubaker</surname><given-names>PH</given-names></name>, <name><surname>Kitzman</surname><given-names>DW</given-names></name> (<year>2007</year>) <article-title>Prevalence and management of chronotropic incompetence in heart failure</article-title>. <source>Curr Cardiol Rep</source>
<volume>9</volume>: <fpage>229</fpage>&#x02013;<lpage>235</lpage>.
<pub-id pub-id-type="pmid">17470336</pub-id></mixed-citation></ref><ref id="pone.0133697.ref040"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Keteyian</surname><given-names>SJ</given-names></name>, <name><surname>Brawner</surname><given-names>CA</given-names></name>, <name><surname>Schairer</surname><given-names>JR</given-names></name>, <name><surname>Levine</surname><given-names>TB</given-names></name>, <name><surname>Levine</surname><given-names>AB</given-names></name>, <name><surname>Rogers</surname><given-names>FJ</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>Effects of exercise training on chronotropic incompetence in patients with heart failure</article-title>. <source>Am Heart J</source>
<volume>138</volume>: <fpage>233</fpage>&#x02013;<lpage>240</lpage>. S0002870399000101 [pii].
<pub-id pub-id-type="pmid">10426833</pub-id></mixed-citation></ref><ref id="pone.0133697.ref041"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Miossi</surname><given-names>R</given-names></name>, <name><surname>Benatti</surname><given-names>FB</given-names></name>, <name><surname>Luciade de Sa</surname><given-names>PA</given-names></name>, <name><surname>Lima</surname><given-names>FR</given-names></name>, <name><surname>Borba</surname><given-names>EF</given-names></name>, <name><surname>Prado</surname><given-names>DM</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial</article-title>. <source>Arthritis Care Res (Hoboken)</source>
<volume>64</volume>: <fpage>1159</fpage>&#x02013;<lpage>1166</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/acr.21678">10.1002/acr.21678</ext-link></comment>
<pub-id pub-id-type="pmid">22438298</pub-id></mixed-citation></ref><ref id="pone.0133697.ref042"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Morton</surname><given-names>RD</given-names></name>, <name><surname>West</surname><given-names>DJ</given-names></name>, <name><surname>Stephens</surname><given-names>JW</given-names></name>, <name><surname>Bain</surname><given-names>SC</given-names></name>, <name><surname>Bracken</surname><given-names>RM</given-names></name> (<year>2010</year>) <article-title>Heart rate prescribed walking training improves cardiorespiratory fitness but not glycaemic control in people with type 2 diabetes</article-title>. <source>J Sports Sci</source>
<volume>28</volume>: <fpage>93</fpage>&#x02013;<lpage>99</lpage>. 918540682 [pii];<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/02640410903365685">10.1080/02640410903365685</ext-link></comment>
<pub-id pub-id-type="pmid">20391086</pub-id></mixed-citation></ref><ref id="pone.0133697.ref043"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Simoneau</surname><given-names>JA</given-names></name>, <name><surname>Lortie</surname><given-names>G</given-names></name>, <name><surname>Boulay</surname><given-names>MR</given-names></name>, <name><surname>Marcotte</surname><given-names>M</given-names></name>, <name><surname>Thibault</surname><given-names>MC</given-names></name>, <name><surname>Bouchard</surname><given-names>C</given-names></name> (<year>1985</year>) <article-title>Human skeletal muscle fiber type alteration with high-intensity intermittent training</article-title>. <source>Eur J Appl Physiol Occup Physiol</source>
<volume>54</volume>: <fpage>250</fpage>&#x02013;<lpage>253</lpage>.
<pub-id pub-id-type="pmid">4065109</pub-id></mixed-citation></ref><ref id="pone.0133697.ref044"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Green</surname><given-names>HJ</given-names></name>, <name><surname>Thomson</surname><given-names>JA</given-names></name>, <name><surname>Daub</surname><given-names>WD</given-names></name>, <name><surname>Houston</surname><given-names>ME</given-names></name>, <name><surname>Ranney</surname><given-names>DA</given-names></name> (<year>1979</year>) <article-title>Fiber composition, fiber size and enzyme activities in vastus lateralis of elite athletes involved in high intensity exercise</article-title>. <source>Eur J Appl Physiol Occup Physiol</source>
<volume>41</volume>: <fpage>109</fpage>&#x02013;<lpage>117</lpage>.
<pub-id pub-id-type="pmid">157274</pub-id></mixed-citation></ref><ref id="pone.0133697.ref045"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Dalgas</surname><given-names>U</given-names></name>, <name><surname>Stenager</surname><given-names>E</given-names></name>, <name><surname>Jakobsen</surname><given-names>J</given-names></name>, <name><surname>Petersen</surname><given-names>T</given-names></name>, <name><surname>Hansen</surname><given-names>HJ</given-names></name>, <name><surname>Knudsen</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Resistance training improves muscle strength and functional capacity in multiple sclerosis</article-title>. <source>Neurology</source>
<volume>73</volume>: <fpage>1478</fpage>&#x02013;<lpage>1484</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1212/WNL.0b013e3181bf98b4">10.1212/WNL.0b013e3181bf98b4</ext-link></comment>
<pub-id pub-id-type="pmid">19884575</pub-id></mixed-citation></ref><ref id="pone.0133697.ref046"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Terzis</surname><given-names>G</given-names></name>, <name><surname>Stratakos</surname><given-names>G</given-names></name>, <name><surname>Manta</surname><given-names>P</given-names></name>, <name><surname>Georgiadis</surname><given-names>G</given-names></name> (<year>2008</year>) <article-title>Throwing performance after resistance training and detraining</article-title>. <source>J Strength Cond Res</source>
<volume>22</volume>: <fpage>1198</fpage>&#x02013;<lpage>1204</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1519/JSC.0b013e31816d5c97">10.1519/JSC.0b013e31816d5c97</ext-link></comment>
<pub-id pub-id-type="pmid">18545188</pub-id></mixed-citation></ref><ref id="pone.0133697.ref047"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Hakkinen</surname><given-names>K</given-names></name>, <name><surname>Newton</surname><given-names>RU</given-names></name>, <name><surname>Gordon</surname><given-names>SE</given-names></name>, <name><surname>McCormick</surname><given-names>M</given-names></name>, <name><surname>Volek</surname><given-names>JS</given-names></name>, <name><surname>Nindl</surname><given-names>BC</given-names></name>, <etal>et al</etal> (<year>1998</year>) <article-title>Changes in muscle morphology, electromyographic activity, and force production characteristics during progressive strength training in young and older men</article-title>. <source>J Gerontol A Biol Sci Med Sci</source>
<volume>53</volume>: <fpage>B415</fpage>&#x02013;<lpage>B423</lpage>.
<pub-id pub-id-type="pmid">9823737</pub-id></mixed-citation></ref><ref id="pone.0133697.ref048"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Hikida</surname><given-names>RS</given-names></name>, <name><surname>Staron</surname><given-names>RS</given-names></name>, <name><surname>Hagerman</surname><given-names>FC</given-names></name>, <name><surname>Walsh</surname><given-names>S</given-names></name>, <name><surname>Kaiser</surname><given-names>E</given-names></name>, <name><surname>Shell</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>Effects of high-intensity resistance training on untrained older men. II. Muscle fiber characteristics and nucleo-cytoplasmic relationships</article-title>. <source>J Gerontol A Biol Sci Med Sci</source>
<volume>55</volume>: <fpage>B347</fpage>&#x02013;<lpage>B354</lpage>.
<pub-id pub-id-type="pmid">10898248</pub-id></mixed-citation></ref><ref id="pone.0133697.ref049"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Lexell</surname><given-names>J</given-names></name>, <name><surname>Taylor</surname><given-names>CC</given-names></name> (<year>1989</year>) <article-title>Variability in muscle fibre areas in whole human quadriceps muscle: how to reduce sampling errors in biopsy techniques</article-title>. <source>Clin Physiol</source>
<volume>9</volume>: <fpage>333</fpage>&#x02013;<lpage>343</lpage>.
<pub-id pub-id-type="pmid">2766678</pub-id></mixed-citation></ref></ref-list></back></article>